Figure 1. Shielded hydrogen bonds confer longer residence time. (a) Schematic of a drug (yellow) bound to a receptor (green), forming, among other interactions, a hydrogen bond (red dashed line). (b) Compared with (a) the greater curvature of the binding site shields the hydrogen bond from water access, creating a larger barrier to drug dissociation. (c) For a less-curved binding site, as in (a), increasing the ligand size (blue) also shields the hydrogen bond. The difficulty with which water diffuses into and away from a shielded hydrogen bond directly impacts drug residence time, by creating a kinetic barrier to ligand binding and unbinding [111]

From

Docking and Ligand Binding Affinity: Uses and Pitfalls

María J. R. Yunta

American Journal of Modeling and Optimization. 2016, 4(3), 74-114 doi:10.12691/ajmo-4-3-2